• ALMR share price: currently unavailable. Sorry, we currently don't have enough data to create an insight.

  • Price change

    The price of ALMR shares has increased $0.68 since the market last closed. This is a 3.44% rise.

  • Closed at $20.44.

    The stock has since dropped $0.04 in after-hours trading.

Key terms

About ALMR

Alamar Biosciences, Inc. engages in developing a proteomic liquid biopsy platform and sells instruments, consumables & services for the early detection of diseases. Its products include ARGO HT system, NULISA assays for Immunology, neurology & oncology, NULISAqpcr custom assay development, technology access program and Alamar analysis solutions. The company was founded by Yuling Luo, Yiyuan Yin and Steve Chen in May 2018 and is headquartered in Fremont, CA.

Sector
Industry
Employees
Founded
Website
Key stock statistics
1-day range
     
52-week range
     
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date
  • Market cap: $1.42B

    A market capitalization between $300 million and $2 billion places ALMR in the small capitalization category.

Key terms

Smart score

Latest ALMR news

May 12, 2026 3:09pm ET Toast downgraded, Lowe’s upgraded: Wall Street’s top analyst calls by TipRanks May 12, 2026 1:01pm ET Alamar Biosciences initiated with an Outperform at Leerink by TipRanks May 12, 2026 6:40am ET Alamar Biosciences initiated with a Neutral at BofA by TipRanks May 12, 2026 6:21am ET Analysts Offer Insights on NA Companies: AEVEX Corp. Class A (AVEX) and Alamar Biosciences, Inc. (ALMR) by TipRanks May 12, 2026 5:36am ET Alamar Biosciences initiated with a Buy at TD Cowen by TipRanks May 12, 2026 4:41am ET Alamar Biosciences initiated with an Overweight at JPMorgan by TipRanks May 12, 2026 4:40am ET Alamar Biosciences initiated with a Buy at Stifel by TipRanks May 11, 2026 2:44pm ET Opening Day: HawkEye 360 jumps in debut after high‑end pricing by TipRanks May 08, 2026 2:02pm ET Alamar Biosciences reports Q1 EPS ($1.74) vs. (68c) last year by TipRanks Apr 20, 2026 11:39am ET Opening Day: Drone maker AEVEX pops on debut by TipRanks Apr 17, 2026 8:10pm ET Cathie Wood’s ARK Investment buys 537.5K shares of Alamar Biosciences today by TipRanks Apr 17, 2026 12:35pm ET Alamar Biosciences opens at $22.60, IPO priced at $17 per share by TipRanks Apr 17, 2026 11:25am ET Alamar Biosciences indicated to open at $20, IPO priced at $17 by TipRanks Apr 17, 2026 6:35am ET Alamar Biosciences 11.25M share IPO priced at $17.00 by TipRanks
May 08, 2026 8:00am ET Alamar Biosciences Reports First Quarter 2026 Financial Results by GlobeNewswire May 05, 2026 4:05pm ET Alamar Biosciences to Participate in BofA Securities 2026 Healthcare Conference by GlobeNewswire

ALMR Financials

1-year income & revenue

  • ALMR total_revenue: currently unavailable. Sorry, we currently don't have enough data to create an insight.

  • ALMR net income: currently unavailable. Sorry, we currently don't have enough data to create an insight.

  • ALMR earnings per share: currently unavailable. Sorry, we currently don't have enough data to create an insight.

Key terms

ALMR Forecasts

analyst rating

  • buy
  • hold
  • sell

We're sorry, but this
information is
temporarily unavailable.

1-year stock price forecast

ALMR Competitors

$ Market cap P/E ratio $ Price 1d change 52-week range
  • How competitors are chosen

    ALMR's competitors are included in the Health Technology sector and Biotechnology group

  • Market cap: $1.42B

    A market capitalization between $300 million and $2 billion places ALMR in the small capitalization category.

Key terms

Latest investing news